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Heparan Sulfate Heterogeneity in Skeletal Muscle Basal Lamina:
Demonstration by Phage Display-Derived Antibodies
Guido J. Jenniskens, Arie Oosterhof, Ricardo Brandwijk, Jacques H. Veerkamp, and Toin H. van Kuppevelt
Department of Biochemistry, Faculty of Medical Sciences, University of Nijmegen, 6500 HB Nijmegen, The Netherlands
The basal lamina (BL) enveloping skeletal muscle fibers con-
tains different glycoproteins, including proteoglycans. To obtain
more information on the glycosaminoglycan moiety of proteo-
glycans, we have selected a panel of anti-heparan sulfate (HS)
antibodies from a semisynthetic antibody phage display library
by panning against glycosaminoglycan preparations derived
from skeletal muscle. Epitope recognition by the antibodies is
strongly dependent on O- and N-sulfation of the heparan sul-
fate. Immunostaining with these antibodies showed a distinct
distribution of heparan sulfate epitopes in muscle basal lamina
of various species. Clear differences in staining intensity were
observed between neural, synaptic, and extrasynaptic basal
laminae. Moreover, temporal and regional changes in abun-
dancy of heparan sulfate epitopes were observed during mus-
cle development both in vitro and in vivo. Taken together, these
data suggest a role for specific heparan sulfate domains/spe-
cies in myogenesis and synaptogenesis. Detailed analysis of
the functions of heparan sulfate epitopes in muscle morpho-
genesis has now become feasible with the isolation of antibod-
ies specific for distinct heparan sulfate epitopes.
Key words: heparan sulfate proteoglycan; glycosaminogly-
can; basal lamina; neuromuscular junction; myogenesis;
synaptogenesis
The basal lamina (BL) enveloping skeletal muscle fibers plays
various roles in muscle development and regeneration (Sanes,
1986; Wright et al., 1991). Several BL molecules have been
identified as specifically synaptic, extrasynaptic, or common
(Sanes, 1982; Hall and Sanes, 1993). On the protein level, these
include isoforms of laminin, collagen, and entactin (Sanes et al.,
1990; Chiu and Ko, 1994; Patton et al., 1997). Lectin staining
(Sanes and Cheney, 1982; Iglesias et al., 1992) and a recent report
on synapse-specific carbohydrates (Martin et al., 1999) indicate a
spatial heterogeneity for carbohydrates as well.
Heparan sulfate proteoglycans (HSPGs), consisting of a core
protein and a carbohydrate moiety [heparan sulfate (HS)], are
main components of muscle BLs. So far, three BL HSPGs have
been identified: perlecan, agrin, and type XVIII collagen
(Noonan et al., 1991; Tsen et al., 1995; Halfter et al., 1998).
HSPGs are implicated in developmental processes underlying
myogenesis and synaptogenesis (Anderson and Fambrough,
1983; Anderson et al., 1984; Bayne et al., 1984; Dmytrenko et al.,
1990). Perlecan may effect neuromuscular junction (NMJ) forma-
tion by binding growth factors (Peng et al., 1998). Agrin, a major
HSPG of the synaptic BL (sBL), orchestrates acetylcholine re-
ceptor (AChR) clustering (Campanelli et al., 1994; Ruegg and
Bixby, 1998). Heparin and HS are involved in AChR clustering
induced by nerve (Hirano and Kidokoro, 1989) and agrin (Wal-
lace, 1990). In muscle cell lines defective in glycosaminoglycan
(GAG) synthesis, a causal relationship between GAGs and
AChR clustering is demonstrated (Ferns et al., 1993; Gordon et
al., 1993; Mook-Jung and Gordon, 1996). HS binding may also
mediate the synapse-specific anchoring of BL-resident proteins
such as acetylcholine esterase and possibly certain laminin iso-
forms (Brandan et al., 1985; San Antonio et al., 1993; Patton et al.,
1997).
Another major characteristic of HS is the binding of growth
factors such as neuregulin (Fischbach and Rosen, 1997), midkine
(Zhou et al., 1997), heparin-binding growth-associated molecule
(Peng et al., 1995; Szabat and Rauvala, 1996), heparin-binding
epidermal growth factor-like growth factor (Chen et al., 1995), and
basic fibroblast growth factor. The latter protein is involved in
postsynaptic differentiation (Peng et al., 1991) and maintenance of
the proliferative state of satellite cells (Rapraeger et al., 1991;
Olwin and Rapraeger, 1992; Olwin et al., 1994; Crisona et al.,
1998). Considering the diversity of proteins that bind HS, HS
molecules may contain unique domains (epitopes) that are specific
for these interactions.
Studies of HSPGs have mainly been focused on the protein core.
The structure and the role of the HS moiety are difficult to inves-
tigate because of a lack of appropriate tools. Only a few antibodies
that recognize HS epitopes have been described (David et al.,
1992; van den Born et al., 1992). Recently, we adapted phage
display technology to obtain epitope-specific antibodies against HS
(van Kuppevelt et al., 1998). Here we report on the isolation,
characterization, and application of antibodies selected against
HS-containing GAG preparations from skeletal muscle. We pro-
vide evidence for the existence of several specific, differentially
distributed HS epitopes in (synaptic and extrasynaptic) muscle and
nerve BLs. Moreover, we found a shift in abundancy of these
epitopes in BLs of developing muscle both in vitro and in vivo.
These data suggest an involvement of specific HS epitopes in
myogenesis and synaptogenesis.
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MATERIALS AND METHODS
Materials. Synthetic single-chain variable fragment (scFv) library #1
(Nissim et al., 1994) was generously provided by Dr. G. Winter (Cam-
bridge University, Cambridge, United Kingdom). Human skeletal mus-
cle samples were generously provided by Prof. Dr. D. Ruiter (Depart-
ment of Pathology, University of Nijmegen, Nijmegen, The
Netherlands). Torpedo marmarota electric organ was generously pro-
vided by Dr. M. H. De Baets (Department of Immunology, University of
Maastricht, Maastricht, The Netherlands). Mice (C3H, male, 70 d), rats
(Wistar, male, six weeks), and rat embryos (Wistar, 10, 13, 16, and 19 d
after conception) were obtained from the University of Nijmegen Cen-
tral Animal Laboratory. C3H mouse-derived skeletal muscle (C2C12) cell
line was purchased from American Type Culture Collection (Rockville,
MD). Glycosaminoglycan-deficient myoblast (S27) cell line was a gener-
ous gift of Dr. Z. Hall (Department of Physiology, University of Cali-
fornia, San Francisco, CA); mutant Chinese hamster ovary (CHO) cell
lines were kindly provided by Dr. J. Esko (Department of Biochemistry,
University of Alabama, Birmingham, AL).
For phage display, two Escherichia coli strains were used: suppressor
strain TG1 [K12, supE, hsdD5, thi D(lac-proAB), F’(traD36, proAB 1,
lacI q, lac ZDM15)] and nonsuppressor strain HB2151 [K12, ara, thi
D(lac-pro), F’( proAB 1, lacI q, ZDM15)]. Helper phage VCS-M13 was
from Stratagene (La Jolla, CA).
All chemicals used were purchased from Merck (Darmstadt, Germa-
ny), unless stated otherwise. Bacterial media (2xTY and LB) and cell
culture media were from Life Technologies (Paisley, Scotland). Chon-
droitinase ABC (from Proteus vulgaris, EC 4.2.2.4), chemically modified
heparin kit, anti-chondroitin sulfate (CS) “stub” antibody (2B6), and
anti-heparan sulfate stub antibody (3G10) were from Seikagaku Kogyo
Co. (Tokyo, Japan). Heparinase III (from Flavobacterium heparinum, EC
4.2.2.8), heparan sulfate from bovine kidney and porcine intestinal mu-
cosa, heparin from porcine intestinal mucosa, chondroitin 4-sulfate and
chondroitin 6-sulfate from bovine trachea, dermatan sulfate (DS) from
porcine intestinal mucosa, keratan sulfate from bovine cornea, hyal-
uronic acid from human umbilical cord, DNA from calf thymus, phenyl-
methylsulfonyl fluoride (PMSF), N-ethylmaleimide, aprotinin, sodium
azide, pepstatin A, and bovine serum albumin (fraction V) were from
Sigma (St. Louis, MO). Microlon 96-well microtiter plates and immuno-
tubes were from Greiner (Frickenhausen, Germany). Anti-c-Myc tag
mouse monoclonal IgG (clone 9E10) was from Boehringer Mannheim
(Mannheim, Germany), Anti-c-Myc tag rabbit polyclonal IgG (A-14) was
from Santa Cruz Biotechnology (Santa Cruz, CA). Alkaline phosphatase-
conjugated rabbit anti-mouse IgG was from Dakopatts (Glostrup, Den-
mark). Alexa 488-conjugated goat anti-rabbit IgG and tetramethylrho-
damine isothiocyanate (TRITC)-conjugated a-bungarotoxin were from
Molecular Probes (Eugene, OR). Mowiol (4–88) was from Calbiochem
(La Jolla, CA). PCR chemicals and Taq polymerase (DNA polymerase
from Thermus aquaticus) were from Promega (Madison, WI), PCR
primers were from Biolegio (Malden, The Netherlands), and restriction
enzyme BstNI was from New England Biolabs (Beverly, MA). ABI Prism
Big Dye Terminator Cycle Sequencing Ready Reaction Kit was from PE
Applied Biosystems (Norwalk, CT).
All experiments were performed at ambient temperature (21°C), un-
less stated otherwise.
Isolation of glycosaminoglycans from skeletal muscle. Mouse and hu-
man skeletal muscle specimens were homogenized, defatted in 20 vol of
acetone at 220°C for 16 hr, and dried in a desiccator. Per gram of muscle
tissue, 4 ml 50 mM sodium phosphate buffer, pH 6.5, containing 2 mM
EDTA, 2 mM cysteine, and 10 U papain were added. Papain digestion
was performed for 16 hr at 65°C, and the remaining debris was pelleted.
Residual protein fragments were removed from the glycosaminoglycans
by mild alkaline borohydride digestion in 0.5 M NaOH/0.05 M NaBH4 at
4°C. After overnight digestion, the mixture was neutralized by addition of
6 M HCl. Residual protein fragments were precipitated by addition of
100% (w/v) trichloroacetic acid to a final concentration of 6% and
precipitation at 0°C for 1 hr. Precipitated proteins were removed by
centrifugation (10,000 3 g for 20 min at 4°C), and glycosaminoglycans
were isolated by addition of 5 vol of 100% ethanol to the supernatant and
overnight precipitation at 220°C. After centrifugation (10,000 3 g for 30
min at 4°C), the pelleted glycosaminoglycans were washed with 70%
ethanol, dried, and dissolved in 10 mM Tris-HCl, pH 6.8. This crude
glycosaminoglycan preparation was further deprived of protein contam-
ination by DEAE Sepharose column chromatography, eluting glycosami-
noglycans at 0.5 M and 1.0 M NaCl in 10 mM Tris-HCl, pH 6.8. GAG-
containing eluates were pooled, and after ethanol precipitation the
residual salt was removed by a 70% (v/v) ethanol wash. The resulting
glycosaminoglycan preparations were dissolved in MilliQ water and
stored at 4°C.
Phage display. Phage display was essentially performed as described
(Van Kuppevelt et al., 1998). Synthetic scFv library #1 was subjected to
four rounds of panning against mouse or human skeletal muscle glycos-
aminoglycan preparations. The library contains approximately 10 8 dif-
ferent scFv antibody clones, composed of 50 different heavy (VH) chain
V segments with synthetic (randomly synthesized) complementarity-
determining region 3 (CDR3) fragments and one light (VL) segment.
This library was in vitro-synthesized from V gene segments, derived from
human lymphocytes, using PCR (Tomlinson et al., 1992; Nissim et al.,
1994). After the last round of selection, single colonies were picked, and
the antibodies expressed by these clones were evaluated for reactivity by
ELISA. Clones displaying reactive antibodies were further analyzed by
colony-PCR amplification of the antibody coding region and restriction
digestion of the full-length PCR products with BstNI (CC* A/TGG).
Unique clones were grown at a larger scale, and individual plasmid DNAs
were sequenced using PelB-seq (59-CCGCTGGATTGTTATTACTC-39)
as a primer (located within the PelB leader sequence).
Large scale preparation of antibodies. To produce large quantities of
scFv antibodies, plasmid DNA from selected clones was used to trans-
form nonsuppressor E. coli strain HB2151. Five hundred milliliters of
Figure 1. Silver-stained 1% agarose gel of a muscle glycosaminoglycan
preparation. Lane 1, Sample buffer (control); lane 2, 5 ng GAG standard;
lane 3, 20 ng GAG standard; lane 4, typical glycosaminoglycan prepara-
tion of mouse skeletal muscle. Dermatan sulfate (DS) is present at
approximately fourfold higher concentration compared with chondroitin
sulfate (CS) and heparan sulfate (HS).
Table 1. CDR3 sequences and germline VH gene segments of anti-HS
scFv antibodies
Clone CDR3 sequence VH family DP segment
AO4B05 LKQQGIS 3 53
AO4B08 SLRMNGWRAHQ 3 47
AO4F12 AMTQKKPRKLSL 1 7
RB4CB9 HAPLRNTRTNT 3 38
RB4CD12 GMRPRL 3 38
RB4EA12 RRYALDY 3 32
RB4EG12 SGRKYFRARDMN 1 4
Antibodies with the prefix AO were obtained after panning against GAGs from
mouse skeletal muscle, whereas antibodies with the prefix RB were selected by
panning against GAGs isolated from human skeletal muscle. CDR3 sequences are
shown in single-letter amino acid code. VH families and DP segments were deduced
from the Sanger Centre Germline Quiry (http://www.sanger.ac.uk/DataSearch/
gq_search.shtml) by applying the full-length VH sequences of the anti-HS scFv
antibody clones (nomenclature according to Tomlinson et al., 1992).
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prewarmed 2xTY medium containing 0.1% (w/v) glucose and 100 mg/ml
ampicillin were inoculated with an overnight culture of transformed
HB2151 and grown with vigorous shaking at 37°C until an OD600 of 0.3
was reached. Induction was effectuated by addition of isopropyl-b-D-
thiogalactopyranoside (IPTG) to a final concentration of 1 mM. After 3
hr incubation at 30°C the culture was cooled on ice for 20 min, and cells
were pelleted (3000 3 g for 10 min at 4°C). One-tenth volume of 103
protease inhibitor mix [0.1 M EDTA, 250 mM iodoacetamine, 1 M
n-ethylmaleimide, 1% (w/v) NaN3, 1.5 mTIU/ml aprotinin, 0.1% (w/v)
pepstatin A, 1 mM PMSF] was added to the supernatant, which was
subsequently divided into aliquots and stored at 4°C. The cells were
resuspended by vigorous vortexing in 5 ml ice-cold 200 mM sodium borate
buffer, pH 8.0, containing 160 mM NaCl, 1 mM EDTA, and protease
inhibitors. After centrifugation (5000 3 g for 30 min at 4°C), the
supernatant (the periplasmic fraction containing the scFv antibodies) was
filtered through a 0.45 mm filter, dialyzed overnight at 4°C against PBS,
divided into aliquots, and stored at 220°C.
Evaluation of antibody specificity by ELISA. Unless stated otherwise,
supernatants of IPTG-induced HB2151 cultures were used for ELISA.
Affinity of the antibodies to various molecules was evaluated by ELISA in
two ways: scFv antibodies were applied to wells of Microlon microtiter
plates, coated with the molecule concerned (10 mg/ml coating solution),
and allowed to bind for 90 min. Alternatively, scFv antibodies were
preincubated overnight with the test molecule (10 mg/ml) in PBS/0.1%
(w/v) Marvel, followed by transfer to and 90 min incubation in wells
previously coated with heparin. Test molecules included glycosaminogly-
can preparations from mouse and human skeletal muscle, HS prepara-
tions from bovine kidney and human lung, prepared as described above,
commercially available heparan sulfate from bovine kidney and from
porcine intestinal mucosa, heparin, chemically and enzymatically modi-
fied heparin, chondroitin 4-sulfate, chondroitin 6-sulfate, dermatan sul-
fate, keratan sulfate, hyaluronic acid, DNA, Marvel, and bovine serum
albumin (fraction V). Bound scFv antibodies were detected using anti-c-
Myc mouse monoclonal antibody 9E10, followed by alkaline
phosphatase-conjugated rabbit anti-mouse IgG (60 min each). Plates
were washed three times with PBS containing 0.1% (v/v) Tween-20
(PBST) after each incubation. Enzyme activity was detected using 1
mg/ml p-nitrophenyl phosphate in 1 M diethanolamine/0.5 mM MgCl2,
pH 9.8, and absorbance was read at 405 nm.
Immunohistochemistry. Periplasmic fractions of IPTG-induced
HB2151 cultures were used for immunohistochemistry, unless stated
otherwise. Location of the epitopes recognized by the antibodies in
several tissues was assessed both on cryosections of tissue specimens and
on monolayers of cultured cell lines. Tissues included human skeletal
muscle and diaphragm, rat and C3H mouse skeletal muscle, rat dener-
vated skeletal muscle, rat embryos, and T. marmarota electric organ.
Tissue specimens were snap-frozen in liquid nitrogen-cooled isopentane
and stored at 280°C. Wild-type and glycosylation-deficient CHO cell
lines were studied at confluency, whereas myoblast (C2C12 and S27) cell
lines were analyzed at various stages of differentiation. Cells were grown
as previously described (Portie´r et al., 1999), differentiated in Ultroser
brain extract medium, washed three times with PBS, dried overnight, and
stored at 280°C. Cryosections (3 or 5 mm) or tissue cultures were
rehydrated for 10 min in PBS, blocked with PBS containing 0.1% (w/v)
BSA for 20 min, and incubated with scFv antibodies for 90 min. Bound
antibodies were detected using anti-c-Myc rabbit polyclonal antibody
A-14 and Alexa 488-conjugated goat anti-rabbit IgG (60 min each). For
visualization of AChR clusters, TRITC-conjugated a-bungarotoxin was
included in the final incubation. Cryosections or tissue cultures were
washed three times with PBS after each incubation. Finally, the cryosec-
tions or tissue cultures were fixed in 100% methanol, dried, and embed-
ded in Mowiol [10% (w/v) in 0.1 M Tris-HCl, pH 8.5/25% (v/v) glycerol /
2.5% (w/v) NaN3]. As a control, primary, secondary, or conjugated
antibodies were omitted.
Evaluation of antibody specificity by immunohistochemistry. To assess
the heparan sulfate specificity of the scFv antibodies, cryosections or
tissue cultures were preincubated with heparinase III to digest heparan
sulfate [0.02 U/ml in 50 mM NaAc/50 mM Ca(Ac)2, pH 7.0] overnight at
37°C, or with chondroitinase ABC, which digests chondroitin and der-
matan sulfate (1 U/ml in 25 mM Tris-HCl, pH 8.0) for 30 min at 37°C. As
a control, cryosections or tissue cultures were incubated in the reaction
buffer without enzyme. After washing three times with PBS and blocking
with PBS/0.1% (w/v) BSA, cryosections and tissue cultures were incu-
bated with antibodies and processed for immunofluorescence as de-
scribed above. The efficiency of chondroitinase ABC treatment was
evaluated by incubation of cryosections with an antibody (2B6) against
chondroitin sulfate “stubs,” generated by chondroitinase. Heparan sul-
fate stubs were visualized using anti-D-heparan sulfate antibody (3G10).
Denervation of rat skeletal muscle. The musculus gastrocnemius and the
musculus soleus of the left legs of young adult rats were denervated by
cutting the efferent motor nerves innervating these muscles. The ends of
these nerves were fastened to the musculus biceps femoris to prevent
reinnervation (Degens et al., 1992). After 11 d, rats were killed, and the
calves of both the left (denervated) and right (control) legs were isolated
and processed as described in immunohistochemistry.
RESULTS
Selection of antibodies against skeletal muscle GAGs
To select scFv antibodies against skeletal muscle GAG epitopes,
GAGs were isolated from human and C3H mouse skeletal mus-
cle. Typically, 10 mg GAG could be purified from 1 gm muscle
tissue (wet weight). All GAG preparations contained approxi-
mately equal amounts of CS and HS and were approximately
fourfold richer in DS (Fig. 1).
Four rounds of panning were performed against mouse skeletal
muscle-derived GAG preparations, resulting in antibodies that
bear the prefix AO. Antibodies with the prefix RB were obtained
after panning against human skeletal muscle-derived GAGs. This
approach yielded a set of unique anti-HS antibodies, based on the
Table 2. Evaluation of anti-HS antibody specificity by ELISA
GAG preparation AO4B05 AO4B08 AO4F12 RB4CB9 RB4CD12 RB4EA12 RB4EG12
K5 capsular polysaccharide (E. coli)a 2 2 2 2 2 2 2
HS (bovine kidney) 11 111 1 1/2 11 1/2 1/2
HS (porcine intestinal mucosa) 11 11 1/2 1 1 1 1/2
HS (human lung, 0.5 M NaCl fraction)b 1 1/2 2 2 2 1 1/2
HS (human lung, 1.0 M NaCl fraction)b 11 111 11 1 11 11 11
Heparin (porcine intestinal mucosa) 11 111 111 1 111 11 111
Heparin, desulfated and N-acetylatedc 2 2 2 2 2 2 2
Heparin, desulfated and N-sulfatedc 2 2 2 2 2 2 2
Heparin, N-desulfated and N-acetylatedc 2 2 1/2 2 2 2 2
Antibody-containing supernatants of IPTG-induced E. coli HB2151 cultures were applied to various GAG preparations immobilized on microtiter plates. Bound antibodies
were detected using anti-c-Myc mouse monoclonal antibody 9E10, followed by alkaline phosphatase-conjugated rabbit anti-mouse IgG, after which enzymatic activity was
measured using p-nitrophenyl phosphate as a substrate. Substrate affinity: 111, very strong; 11, strong; 1, moderate; 1/2, weak; 2, absent (n 5 5).
aSimilar to the HS precursor polysaccharide.
bHS fraction eluting from anion exchange column at the NaCl concentration indicated.
cInhibition-ELISA.
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amino acid sequence of their heavy chain CDR3, a major deter-
minant in antigen specificity (Table 1).
Characterization of antibodies
All antibodies showed a high reactivity in ELISA for the GAG
preparation against which they were selected, whereas the reac-
tivity for various GAG species derived from other tissues varied
significantly. Despite the fact that the antibodies were selected
against a GAG mixture that consisted predominantly of DS,
antibodies showed affinity only for HS and heparin. No reactivity
was observed with chondroitin 4-sulfate, chondroitin 6-sulfate,
dermatan sulfate, keratan sulfate, hyaluronic acid, DNA, Marvel
(blocking agent), and Microlon (data not shown). Antibodies
reacted to various extents with a highly sulfated HS fraction
(eluting at 1.0 M NaCl in ion exchange chromatography) and with
a low-sulfated fraction (eluting at 0.5 M NaCl) of human lung
(Table 2). All antibodies showed a major cross-reactivity with
heparin, which is highly sulfated. Antibodies AO4B05, AO4B08,
and (to a somewhat lesser extent) RB4CD12 showed a high
reactivity for HS from bovine kidney and porcine intestinal
mucosa, whereas all other antibodies interacted only moderately
or weakly. K5 capsular polysaccharide from E. coli, which is
similar to the HS precursor, was not bound by any of the
antibodies.
To investigate which chemical groups are recognized by the
different antibodies, we determined the reactivity of the antibod-
ies toward modified heparin preparations (Table 2). Completely
desulfated and N-acetylated heparin as well as completely desul-
fated and N-sulfated heparin were not recognized by any of the
antibodies. Heparin that was N-desulfated and N-acetylated also
was not recognized by the antibodies, except for AO4F12, which
showed a weak binding.
To ascertain the HS specificity of the antibodies, immunoflu-
orescence studies were performed on cryosections of skeletal
muscle tissue that were treated with heparinase III before incu-
bation. Heparinase treatment of cryosections resulted in a total
loss of staining for all antibodies (Fig. 2), whereas treatment with
chondroitinase ABC did not (data not shown). Staining of
heparinase-treated cryosections with anti-HS stub antibody 3G10
(which reveals all HS that is present) showed HS to be equally
distributed in synaptic and extrasynaptic BL (Fig. 2c).
Cell lines that are defective in GAG synthesis are not
surface-stained by anti-HS antibodies
To further establish the anti-HS nature of the scFv antibodies, we
investigated cell lines that are defective in GAG synthesis. De-
velopmental stages from half-confluent to 8 d of differentiation of
the S27 cell line (Gordon and Hall, 1989) and confluent cultures of
different CHO cell lines [wild type, N-acetylglucosaminyl- and
glucuronosyltransferase-deficient; pgsD-677 (Lidholt et al., 1992),
heparan sulfate uronic acid 2-O-sulfotransferase deficient;
pgsF-17 (Dr. J. Esko, personal communication), and xylosyl trans-
ferase deficient; pgsA-745 (Esko et al., 1985)] were analyzed by
immunofluorescence.
In contrast to wild-type myoblast cell line C2C12 (see below),
the surface of S27 myoblasts was not immunoreactive for any of
the antibodies, nor were places of cell–cell contact. On alignment
and fusion, and at day 8 of differentiation, myotubes were not
stained either, indicating that the BL of this mutant cell line does
not contain any of the HS epitopes recognized by any of the
antibodies (Table 3, Fig. 3). A noteworthy observation was the
distinct staining of perinuclear and cytosolic granules by some
antibodies (Table 3).
Wild-type CHO cells showed a clear surface staining at sites of
cell–cell contact when incubated with antibodies AO4B05,
AO4B08, AO4F12, RB4CB9, and RB4CD12 (Table 3, Fig. 4a,b),
whereas incubation with RB4EA12 and RB4EG12 did not (Table
3, Fig. 4c). None of the glycosylation-defective CHO mutant cell
lines showed any surface staining (Fig. 4). As in the S27 cell line,
some antibodies showed a distinct staining of perinuclear and
cytosolic granules (Table 3, Fig. 4).
Anti-HS antibodies bind distinct HS epitopes in
skeletal muscle basal lamina
Incubation of cryosections of human, rat, and mouse skeletal
muscle with each of the anti-HS antibodies yielded a clear stain-
ing of the muscle BL, which was similar in the species examined
(Table 3, Fig. 5). Staining patterns of the antibodies on muscle BL
were mutually distinct, ranging from a strong staining of the
entire BL (AO4B05, AO4B08, AO4F12, RB4CB9, and
Figure 2. Staining of heparinase III-treated skeletal muscle cryosections
with anti-HS scFv and anti-HS stub antibodies. Nontreated (a) and
heparinase III-treated (b, c) cryosections of mouse skeletal muscle tissue
were incubated with periplasmic fraction of anti-HS antibody AO4F12 (a,
b) or anti-heparan sulfate stub antibody (3G10) (c). Bound scFv antibod-
ies were visualized by incubation with rabbit polyclonal anti-c-Myc IgG
(a1, b1), followed by Alexa 488-conjugated goat anti-rabbit or anti-mouse
IgG (a and b, or c, respectively). AChR clusters present in the neuromus-
cular junction were visualized using TRITC-conjugated a-bungarotoxin
(a2–c2). Although in untreated tissue the AO4F12 epitope is clearly
present in the muscle BL (a1), staining disappeared during heparinase
treatment (b1), indicating the HS nature of the epitope. Staining of
heparan sulfate stubs in heparinase-treated tissue showed HS to be
present throughout the muscle BL (c1). Note the higher staining intensity
of AO4F12 at NMJs (a1, a2, arrows), regardless of the overall quantity of
HS in the NMJ (c1, c2, arrows). Scale bar, 50 mm.
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RB4CD12), to a staining concentrated in (RB4EA12), or almost
exclusive for (RB4EG12) the sBL. Antibodies AO4B05, AO4F12,
RB4CD12, RB4EA12, and RB4EG12 stained the sBL more in-
tensely than the extrasynaptic BL. The BL of neural tissues
showed very strong (AO4F12, RB4CD12, and RB4EA12), strong
(AO4B05), or moderate (AO4B08, RB4CB9, and RB4EG12)
staining. BLs of blood vessels showed strong to moderate
(AO4B05, AO4B08, AO4F12, RB4CB9, and RB4CD12) or no
(RB4EA12 and RB4EG12) staining. The latter two antibodies
hardly stain muscle BL extrasynaptically and appear to be
neuron- and synapse-specific. Most antibodies that stain blood
vessels showed differences in staining intensity between arteries,
large blood vessels, and capillaries.
The staining patterns of anti-HS antibodies provided con-
vincing evidence for the existence and unique distribution of
multiple HS epitopes within the skeletal muscle BL. To inves-
tigate the distribution of these HS epitopes with regard to the
sBL, cryosections containing NMJs were incubated both with
the antibodies and with TRITC-conjugated a-bungarotoxin.
a-Bungarotoxin exclusively binds AChRs, thus allowing iden-
tification of NMJs. The AO4F12 epitope does not fully colo-
calize with AChR clusters, yet there is considerable overlap
between the distribution of the AO4F12 epitope in the sBL
and the presence of dense patches of AChR on the postsyn-
aptic membrane (Fig. 5a1–a3). RB4CD12, on the other hand,
showed an almost complete colocalization with AChR clusters
(Fig. 5b1–b3). RB4EA12 showed a strong preference for neural
and synaptic BL, thus completely colocalizing with AChR
clusters in NMJs (Fig. 5c1–c3). Finally, the RB4EG12 epitope
showed a moderate staining that was limited to neural and
synaptic BLs only (Fig. 5d1–d3).
HS epitopes recognized by anti-HS antibodies abound
in T. marmarota electric organ
Because the anti-HS antibodies showed differential staining
patterns with regard to nerve- and muscle-derived (extrasyn-
Table 3. Immunostaining patterns of anti-HS antibodies
Tissue AO4B05 AO4B08 AO4F12 RB4CB9 RB4CD12 RB4EA12 RB4EG12
Mature human, rat, and mouse skeletal muscle
Extrasynaptic basal lamina 11 11 11 11 11 1/2 2
Synaptic basal lamina 111 11 111 11 111 111 1
Endoneurium and perineurium 11 1 111 1 111 111 1
Capillary basal lamina 11 11 11 1 111 2 2
Arterial basal lamina 11 1 11 11 11 2 2
Electric organ (T. marmarota)
Electrocyte, noninnervated face 11 1 1 1/2 11 1/2 1
Electrocyte, innervated face 11 1 1 11 11 1/2 1
Endoneurium 11 1 1 2 1 1/2 1
Perineurium 1/2 1 11 11 1 2 1/2
Rat embryo skeletal muscle (19 d in utero)
Extrasynaptic basal lamina 11 11 11 1 111 2 1/2
Synaptic basal lamina 11 11 111 11 11 2 11
Nerve basal lamina 11 11 111 11 111 1/2 1
Smooth muscle basal lamina (artery) 11 11 11 11 11 2 2
C2C12 skeletal muscle cell line
Cell surface (on contact places) 111 11 11 11 111 2d 2d
Basal lamina (during differentiation) 11a 11a 11a 1 111b 2d 2d
AChR clusters 11a 11 1a 11 111 2 2
S27 cell line (defective in proteoglycan synthesis)
Cell surface (on contact places) 2 2d 2d 2d 2c 2d 2d
Basal lamina (during differentiation) 2 2d 2d 2d 2c 2d 2
CHO cell line (wild type)
Cell surface 11 11 11 1 1 2c 2d
CHO cell line (677 mutant)
Cell surface 2 2 2d 2c 2c 2c 2d
CHO cell line (F17 mutant)
Cell surface 2 2d 2d 2c 2 2d 2d
CHO cell line (745 mutant)
Cell surface 2 2 2 2c 2c 2d 2d
Cryosections of human, rat, and mouse skeletal muscle, T. marmarota electric organ, and rat embryo, as well as fixed monolayers of CHO (wild-type and glycosylation-deficient
mutants, grown to confluency), and C2C12 and S27 cells (differentiated for 0–15 d) were incubated with periplasmic fractions containing anti-HS scFv antibodies. Bound
antibodies were visualized by incubation with rabbit polyclonal anti-c-Myc IgG followed by Alexa 488-conjugated goat anti-rabbit IgG. AChR clusters present in muscle
neuromuscular junction, T. marmarota electrocytes, and C2C12 myotubes were visualized using TRITC-conjugated a-bungarotoxin. Staining intensity: 111, very strong; 11,
strong; 1, moderate; 1/2, weak; 2, absent [n 5 3 (cryosections), n 5 2 (tissue cultures)].
aStaining intensity decreased with differentiation level.
bStaining intensity increased with differentiation level.
cSmall granules within the cytosol: 11.
dSmall granules around the nucleus: 11.
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aptic and synaptic) BLs, and to investigate whether the HS
epitopes are present in nonmammalian species as well, we
tested the antibodies for BL staining in the electric organ of the
electric ray (T. marmarota). The electric organ is evolutionary
derived from muscle tissue and shows dense patches of AChR
clustering on the innervated face of the electrocytes. The
various anti-HS antibodies showed a distinct staining of the
electric organ (Table 3, Fig. 6), ranging from a strong staining
of both electrocyte and endoneural BLs [AO4B05 (Fig. 6a1–
a4 ), AO4B08, AO4F12 (Fig. 6b1–b4 ), and RB4CD12], to a
predominantly strong [RB4CB9 (Fig. 6c2–c4 )], moderate
(RB4EG12) or weak (RB4EA12) staining of the electrocyte
BL. AO4B08, AO4F12 (Fig. 6b2–b4 ), and RB4CD12 stained
specific regions of the electrocyte with a higher intensity.
AO4F12 (Fig. 6b1), RB4CB9 (Fig. 6c1), and, to a lesser extent,
AO4B08 and RB4CD12 stained the perineural BL. The endo-
neural BL was strongly stained by AO4B05 (Fig. 6a1) and to a
lesser extent by AO4B08, AO4F12 (Fig. 6b1), RB4CD12, and
RB4EG12.
Double-label micrographs of the epitope recognized by
AO4B05 with a-bungarotoxin showed that the AO4B05 epitope
partially colocalizes with the dense patches of AChR clusters on
the innervated face of the electrocytes (Fig. 6a4). Double labeling
of the AO4F12 epitope showed a slightly lower staining intensity
of the noninnervated membrane, as compared with the inner-
vated membrane, except for some brightly stained regions (Fig.
6b4). The RB4CB9 epitope was almost exclusively located at the
electrocyte-innervated face, virtually completely colocalizing
with the AChR clusters (Fig. 6c4).
Anti-HS antibodies show a developmental occurrence
of HS epitopes in skeletal muscle basal lamina
The diversity of staining patterns obtained with the antibodies in
mature skeletal muscle prompted us to investigate the occurrence
of HS epitopes during muscle development. Special attention was
paid to changes in the occurrence of specific HS epitopes within
the endomysial, neural, and synaptic BL. This study was per-
formed in three ways. First, cryosections of rat embryos at various
developmental stages (days 10, 13, 16, and 19 in utero) were
studied. In this way, the occurrence of and possible changes in
BL–HS epitopes during muscular development and synaptogen-
esis could be studied in the presence of both muscular and neural
tissue. Second, cultures of the mouse skeletal muscle cell line
C2C12 at developmental stages ranging from half-confluent to
15 d of differentiation were analyzed. In doing so, we could
monitor the presence of and changes in HS epitopes during
myogenesis, as well as during the clustering of AChRs in the
presence of muscular tissue only. Third, cryosections of dener-
vated skeletal muscle of rat were studied. In denervated muscle
cells, we looked at a possible upregulation or downregulation of
HS epitopes as a result of the regeneration process.
In early embryonic stages of the rat (days 10–16), strong stain-
ing of the endomysial as well as a distinct interaction with neural
BL was observed on immunostaining with AO4B05, AO4B08,
AO4F12, RB4CB9, and RB4CD12. Antibody RB4EA12 predom-
inantly stained neural tissue, whereas RB4EG12 showed an amor-
phous staining in developing muscle regions (data not shown).
Rat embryos at day 19 in utero showed a more defined organ
texture in cryosections, which enabled us to examine the presence
Figure 3. Staining of S27 muscle cell line with
anti-HS scFv antibodies. S27 cultures were grown to
confluency and subsequently differentiated up to
8 d. Cultures of different developmental stages
[half confluent (a1–c1), 1 d (a2–c2), and 8 d (a3–
c3) of differentiation] were fixed and subsequently
incubated with the periplasmic fraction of scFv
antibodies AO4B05 (a), RB4CD12 (b), and
RB4EA12 (c), respectively. Bound antibodies
were visualized by incubation with rabbit poly-
clonal anti-c-Myc IgG followed by Alexa 488-
conjugated goat anti-rabbit IgG. None of the
epitopes recognized by any of the antibodies can
be visualized at the surface of myoblasts (a1–c1).
For AO4B05, staining is not visible in aligning
myoblasts (a2) or during myotube formation (a3).
The epitope recognized by RB4CD12 is present in
perinuclear granules in myoblasts (b1, arrows).
During the alignment of myoblasts, the granular
staining around the nucleus persists (b2, arrows) to
change into a predominant cytosolic granular
staining during myotube formation (b3). ScFv an-
tibody RB4EA12 strongly stains perinuclear gran-
ules in myoblasts (c1, arrows). In aligning myo-
blasts and during myotube formation, the granular
staining around the nucleus persists (c2, c3, ar-
rows). Scale bar, 25 mm.
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of the HS epitopes in greater detail (Table 3, Fig. 7). Although
RB4CD12 showed a strong staining of the entire neural and
endomysial BL, the staining intensity was markedly lower in the
sBL (Fig. 7a). RB4CB9, on the other hand, stained the sBL
considerably stronger than the extrasynaptic BL (Fig. 7b).
RB4EG12, binding HS epitopes present in neural and synaptic
BL in fully developed skeletal muscle, strongly interacted with
HS epitopes within the sBL and showed a faint, although definite
staining of the extrasynaptic BL (Fig. 7c). The epitope recognized
by RB4EA12, preferentially staining neural tissue and sBL in
mature muscle, could hardly be visualized in BL of skeletal
muscle tissue at day 19 of rat embryogenesis. However, this
antibody did stain large cytosolic granules (Fig. 7d). Staining of
BL in tissues other than skeletal muscle was also observed (data
not shown).
Cultures of mouse skeletal muscle cell line C2C12 were incu-
bated with antibodies at stages ranging from half-confluent to
15 d of differentiation (Table 3, Figs. 8–10). Immunostaining with
AO4B05, AO4B08, AO4F12, RB4CB9, and RB4CD12 resulted in
a strong staining of the myoblast surface. An intense staining was
observed at places where myoblasts made contact. However, on
alignment and fusion (processes that trigger BL formation), the
entire myotube surface was stained. AChR clusters, which de-
velop on the surface of multinucleated myotubes at approxi-
mately day 3 of differentiation, were also stained by these anti-
bodies. AO4B05 (Fig. 8), RB4CB9, and RB4CD12 (Fig. 9),
especially, showed an enhanced staining of the myotube BL at
sites of AChR clustering. A striking feature was that the overall
staining intensity decreased strongly during differentiation for
antibodies AO4B05 (Fig. 8), AO4B08, and AO4F12. Antibodies
RB4EA12 and RB4EG12 were not able to stain the surface of
C2C12 cells at any stage of differentiation. Both antibodies stained
small cytosolic granules that were predominantly present near the
nuclei (Fig. 10).
Incubation of cryosections of rat skeletal muscle 11 d after
denervation with various anti-HS antibodies did not result in
staining patterns that were any different from control muscle.
After heparinase treatment, no differences in staining intensity
with anti-HS stub antibody 3G10 could be seen in BLs of dener-
vated versus control muscle (data not shown).
DISCUSSION
In this paper, we report the selection of a set of unique anti-HS
scFv antibodies. The HS epitopes recognized by these antibodies
Figure 4. Staining of wild-type and glycosylation-
deficient CHO cell lines with anti-HS scFv antibod-
ies. CHO cultures [wild type (a1–c1), N-acetyl-
glucosaminyl- and glucunorosyltransferase-deficient
pgsD-677 (a2–c2), heparan sulfate uronic acid 2-O-
sulfotransferase-deficient pgsF-17 (a3–c3), and xylo-
syl transferase-deficient pgsA-745 (a4–c4)] were
grown to confluency and subsequently fixed and in-
cubated with the periplasmic fraction of scFv anti-
bodies AO4B05 (a), RB4CD12 (b), and RB4EA12
(c), respectively. Bound antibodies were visualized
as in Figure 3. The AO4B05 epitope is present to a
high degree at the surface of wild-type CHO cells
where cell–cell contacts are made (a1, arrowhead).
Staining is not visible in any of the CHO mutant cell
lines (a2–a4). Wild-type CHO cells are moderately
stained at the surface by antibody RB4CD12 at
places of cell–cell contact (b1, arrowhead). In CHO
mutant cell line pgsD-677 a faint granular perinuclear
staining is visible (b2, arrow), whereas cell lines
pgsF-17 and pgsA-745 show a slightly elevated back-
ground staining (b3 and b4, respectively). The
epitope recognized by RB4EA12 does not appear at
the surface in any of the CHO cell lines but shows a
distinct, perinuclear, and granular staining in all
CHO cell lines used. In wild-type, pgsD-677, and
pgsF-17 cells, these granules are predominantly lo-
cated at the perinuclear region on one side of the cell
(c1–c3, arrows). In pgsA-745 cells, the granular stain-
ing is present around the entire nucleus (c4). Scale
bar, 25 mm.
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are shown to be differentially distributed in BLs of both devel-
oping and mature skeletal muscle. GAG preparations isolated
from mouse and human skeletal muscle specimens were used to
select a series of anti-HS antibodies by phage display. Despite the
enrichment of the muscle GAG preparations for DS, only anti-HS
antibodies were selected. To our knowledge, no anti-DS antibod-
ies have been described so far.
In ELISA, all anti-HS scFv antibodies showed a differential
reactivity with several HS preparations and with heparin, reflect-
ing the epitope specificity of each antibody. The requirement of
both N- and O-sulfate groups for proper epitope recognition was
shown by desulfation of heparin, which is known for its high
number of disaccharide units and high levels of N-sulfation.
Desulfation completely abolished recognition by all antibodies,
and N-resulfation could not restore the heparin–antibody inter-
action. Because CS and DS are not bound by any of the antibod-
ies, sulfation patterns specific for HS are likely to be important in
the structure of the epitopes involved.
In our experiments, CHO cells showed a distinct HS staining
for most antibodies, which was less intense than the staining of
C2C12 cells. This is probably because HS from CHO cells is
relatively poorly sulfated [40–45% N-sulfation and ;0.8 sulfate/
disaccharide (Bame et al., 1991)]. None of the cell-surface HS
epitopes recognized by any of the antibodies described here could
be detected in cell lines that are defective in GAG synthesis. This
was the case with the S27 cell line, a genetic variant of the C2
mouse skeletal muscle cell line, which is severely hampered in
GAG synthesis but does align and fuse to form myotubes during
differentiation (Gordon and Hall, 1989). Several CHO mutants
defective in GAG synthesis caused by the loss or impaired func-
tioning of enzymes involved in glycosylation (Esko et al., 1985;
Lidholt et al., 1992) failed to show any cell surface staining, which
Figure 5. Staining of mouse skeletal muscle basal lamina with anti-HS scFv antibodies. Cryosections of C3H skeletal muscle were incubated with
periplasmic fractions of anti-HS antibodies AO4F12 (a), RB4CD12 (b), RB4EA12 (c), and RB4EG12 (d), respectively. Bound antibodies were
visualized by incubation with rabbit polyclonal anti-c-Myc IgG followed by Alexa 488-conjugated goat anti-rabbit IgG (a1–d1). AChR clusters present
in the neuromuscular junction were visualized using TRITC-conjugated a-bungarotoxin (a2–d2). Double-label micrographs (a3–d3) show in yellow the
colocalization of the HS epitopes bound by the scFv and AChR clusters. The epitope recognized by AO4F12 is present in endoneural and perineural
as well as in endomysial BLs, but is clearly more abundant in synaptic versus extrasynaptic BL (a1). Note that this epitope does not fully colocalize with
AChR clusters; there is a clear overlap from the BL epitope recognition ( green) via a zone in which both epitopes are present ( yellow) to the dense
patches of AChR (red) (a3). The RB4CD12 epitope is also present throughout neural and endomysial BLs and is slightly more abundant at NMJs (b1)
but covers the entire region of AChR clustering (b3). Antibody RB4EA12 stains epitopes present in neural BL to a larger extent than those present in
endomysial BL (c1, c3, arrows), shows a high abundancy in sBL (c1), and covers areas of AChR clustering entirely (c3). The epitope recognized by
RB4EG12 hardly stains endomysial BL but resides in neural BL and at NMJs (d1), where it does not completely cover areas of AChR clustering (d3).
Scale bar, 50 mm.
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indicates their inability to properly synthesize the HS epitopes
involved. The granular staining seen with some antibodies in
many cells may reflect the staining of certain cellular compart-
ments such as the Golgi apparatus or lysosomes. Because of the
defective cellular machinery for the correct synthesis of GAGs,
immature HS epitopes or degradation products of HS molecules
may be confined to these organelles.
All anti-HS scFv antibodies showed distinct reactivity in im-
munofluorescence with the BL of mature skeletal muscle. Stain-
ing patterns of the antibodies on human and rat muscle were
consistent with those obtained on mice, reflecting an interspecies
conservation of the epitopes involved. Most antibodies stained
the entire muscular BL, but some antibodies showed a more
intense staining in synaptic regions. Because of the presence of
junctional folds in the postsynaptic membrane, BL is two- to
threefold more abundant at NMJs than extrasynaptically (Sanes
and Chiu, 1983). This local concentration of BL might explain the
higher staining intensity of some antibodies at the NMJ, but we
did not observe a higher abundance of HS in the synaptic cleft by
heparitinase III digestion and anti-stub staining. A more appeal-
ing explanation is the possibility that certain HS epitopes are
specifically concentrated in the sBL. The incomplete overlap of
the AO4F12 epitope with AChR clusters, in contrast with e.g.,
RB4CD12 and RB4EA12 (Fig. 5), suggests differences in location
of these epitopes within the sBL. Antibodies that predominantly
recognize epitopes present in neural and synaptic BL, such as
RB4EA12 and RB4EG12, may indicate the neural origin of the
epitopes involved. Results obtained on aneurally cultured skeletal
muscle cells support this view, because these antibodies did not
stain BLs at sites of AChR clustering (see further). The synapse-
Figure 6. Staining of Torpedo electric
organ with anti-HS scFv antibodies.
Cryosections of Torpedo electric organ
were incubated with periplasmic frac-
tions of anti-HS scFv antibodies AO4B05
(a), AO4F12 (b), and RB4CB9 (c), re-
spectively. Bound antibodies (a1–c1 and
a2–c2) and AChR clusters (a3–c3) were
visualized as in Figure 5. Double-label
micrographs (a4–c4 ) show in yellow the
colocalization of AChR clusters and
the HS epitopes bound by the scFvs. The
AO4B05 epitope is present in large quan-
tities in the endoneurium (a1, asterisks)
and in electrocyte BLs (a2) but hardly at
all in the perineurium (a1, arrows). Dou-
ble staining of electrocytes reveals that
this epitope is present not only on the
innervated face but throughout the elec-
trocyte BL (a4, arrows). The epitope rec-
ognized by AO4F12 is present in the
endoneurium (b1, asterisk) but is more
abundant in the perineural BLs (b1, ar-
rows). In electrocytes, the presence of
this epitope on the innervated face is less
pronounced, whereas specific regions of
the noninnervated membrane accommo-
date the epitope in large amounts (b2).
Double staining shows this epitope to be
partially colocalized with AChR clusters
on the electrocyte-innervated membrane
(b4 ). The endoneurium is not stained by
antibody RB4CB9 (c1, asterisk), whereas
this epitope is very abundant in the per-
ineurium (c1, arrows). In electrocytes, its
presence is restricted to the innervated
membrane (c2–c4 ). Scale bar, 50 mm.
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specific occurrence of distinct HS epitopes may prove to be causal
for the restricted location of NMJ-resident, HS-binding proteins
such as agrin, acetylcholine esterase, growth factors, and certain
laminin isoforms.
Most HS epitopes recognized by the antibodies proved to be
located close to AChR clusters, present on the innervated face of
electrocytes, in the electric organ of the electric ray (T. mar-
marota). Anti-HS antibodies recognized their epitopes, which
were embedded in mutually distinct patterns and quantities
within neural BLs and in BLs on both the innervated and non-
innervated side of the electrocytes. Despite the conserved distri-
bution of the epitopes with regard to neural, synaptic, and extra-
synaptic BL among the mammals tested, the distribution within
the elasmobranch electric organ appeared to differ. Extracellular
matrix isolated from Torpedo electric organ can induce AChR
clustering in fibroblasts (Hartman et al., 1991). The heavily gly-
cosylated HSPG agrin appears to be involved in the clustering of
AChR in Torpedo electrocytes (Cartaud et al., 1996). The stain-
ing patterns of our anti-HS antibodies on cryosections of the
electric organ add proof to the mutually distinct HS epitopes
involved and raise curiosity about their function in organ
morphogenesis.
During myogenesis in developing rat embryos, some of the HS
epitopes were present in endomysial and synaptic BL in a pattern
different from that seen in mature muscular tissue. Because NMJs
appear between day 14 and 16 of embryonic life (Engel, 1994), the
occurrence of HS epitopes during synaptogenesis was investi-
Figure 7. Staining of rat embryo skeletal muscle with anti-HS scFv
antibodies. Cryosections of rat embryos (day 19 in utero) were incubated
with periplasmic fractions of anti-HS scFv antibodies RB4CD12 (a),
RB4CB9 (b), RB4EG12 (c), and RB4EA12 (d), respectively. Bound
antibodies (a1–d1) and AChR clusters (a2–d2) were visualized as in
Figure 5. The epitope recognized by antibody RB4CD12 is present
throughout neural (asterisk) and endomysial BLs (a1) and is slightly less
abundant in the sBL of developing NMJs (a1, a2, arrow). The epitope
recognized by RB4CB9 is present in smooth muscle BL (arrowheads point
at an artery) throughout the endomysial BL (b1) but is more abundant at
NMJs (b1, b2, arrows). RB4EG12 stains, at a low level, throughout the
endomysial BL (granular staining in c1), but the epitope involved is more
abundant at developing NMJs (c1, c2, arrows). The epitope recognized by
RB4EA12 is only slightly present in the endomysial BL (d1) and absent in
sBL (d1, d2, arrows). Scale bar, 25 mm.
Figure 8. Staining of C2C12 muscle cell line with scFv antibody AO4B05
during differentiation. C2C12 cultures were grown to confluency and
subsequently differentiated up to 15 d. Cultures of different developmen-
tal stages [half confluent (a), 1 d ( b), 8 d (c1, c2), and 15 d (d1, d2) of
differentiation] were fixed and subsequently incubated with the periplas-
mic fraction of scFv antibody AO4B05. Bound scFv antibodies (a, b, c1,
d1) and AChR clusters present on the surface of multinucleated myotubes
(c2, d2) were visualized as in Figure 5. The epitope recognized by
AO4B05 is present to a high degree at the surface of myoblasts in regions
where cell–cell contacts are made (a). In aligning myoblasts (b), a clear
surface staining is visible that becomes more pronounced after myotube
formation at sites where AChR clusters develop (c1, c2, arrows). As
differentiation proceeds, both the staining of the BL and the staining at
AChR clusters decrease (d1, d2, arrows). Scale bar, 25 mm.
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gated on cryosections of embryos at days 10–19 in utero. Most
antibodies stained endomysial as well as neural BLs during em-
bryonic muscular development, as may be expected on the basis
of their staining patterns in mature skeletal muscle tissue. How-
ever, clear differences in developmental appearance could be
distinguished for epitopes recognized by some antibodies
(RB4CB9, RB4CD12, RB4EA12, and RB4EG12), especially at
sites of synaptogenesis. Local binding of growth factors and
cytokines to specific HS sequences, as reviewed recently by Lyon
and Gallagher (1998), may prove to be elemental in tissue mor-
phogenesis. The distinct distribution in both time and space of
these HS epitopes argues for such a regulatory mechanism.
The HS epitopes recognized by our antibodies were present in
C2C12 skeletal muscle cells at various stages of differentiation.
Aneurally grown C2C12 myoblasts start aligning when they reach
confluency. When culture medium is changed to differentiation
medium containing 10% rat brain extract, AChR clusters appear
at approximately day 3 of differentiation (Portie´r et al., 1999). On
mutual contact, C2C12 myoblasts expressed most of the HS
epitopes described in this paper in large quantities on their
surface. Alignment and fusion resulted in a complete staining of
the newly formed BL by corresponding antibodies. These obser-
vations are in accordance with the threefold increase in HS
synthesis in myotube cultures, compared with proliferating or
aligning cultures (Noonan et al., 1986). Some antibodies showed
steady levels or even a marked increase in overall staining inten-
sity of the BL during further differentiation, consistent with the
upregulation of the HSPG glypican during C2C12 differentiation
(Brandan et al., 1996). Overall BL staining intensity of other
antibodies decreased during later stages of differentiation. These
results may be related to observations of Larraı´n et al. (1997a,b)
on downregulation of the HSPGs perlecan and syndecan-1 during
C2C12 cell differentiation. AChR cluster formation was accompa-
Figure 9. Staining of C2C12 muscle cell line with scFv antibody
RB4CD12 during differentiation. C2C12 cultures were grown to conflu-
ency and subsequently differentiated up to 15 d. Cultures of different
developmental stages [half confluent (a), 1 d (b), 8 d (c1, c2), and 15 d
(d1, d2) of differentiation] were fixed and subsequently incubated with the
periplasmic fraction of scFv antibody RB4CD12. Bound scFv antibodies
(a, b, c1, d1) and AChR clusters present on the surface of multinucleated
myotubes (c2, d2) were visualized as in Figure 5. The RB4CD12 epitope
can be visualized at the myoblast surface at sites where cells have made
mutual contacts (a). Note the perinuclear staining of the myoblasts at
half-confluent stage (a, arrowheads). After alignment, a strong surface
staining is visible (b). During myotube formation, this staining intensifies,
especially at sites of AChR clustering (c1, c2, arrows). Ongoing differenti-
ation does not lead to reduced AChR cluster staining, whereas the overall
staining of the BL decreases slightly (d1, d2, arrows). Scale bar, 25 mm.
Figure 10. Staining of C2C12 muscle cell line with scFv antibody
RB4EA12 during differentiation. C2C12 cultures were grown to conflu-
ency and subsequently differentiated up to 15 d. Cultures of different
developmental stages [half confluent (a), 1 d (b), 8 d (c1, c2), and 15 d
(d1, d2) of differentiation] were fixed and subsequently incubated with the
periplasmic fraction of scFv antibody RB4EA12. Bound scFv antibodies
(a, b, c1, d1) and AChR clusters present on the surface of multinucleated
myotubes (c2, d2) were visualized as in Figure 5. The epitope recognized
by RB4EA12 is not present at the surface of myoblasts in regions where
cell–cell contacts have been made (a). Note the faint staining in the
perinuclear region of myoblasts at the half-confluent stage (a, arrow-
heads). A granular staining within the cytosol is visible in early stages of
alignment (b) but disappears during myotube formation (c1). During
further differentiation, no BL staining is seen at AChR clusters (d1, d2,
arrows). Nevertheless, a faint perinuclear staining occurs in some myo-
tubes displaying AChR clusters (d1, d2, arrows). Scale bar, 25 mm.
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nied by a strong local increase of certain HS epitopes, arguing for
a possible role of these epitopes in the clustering of this ion
channel. Antibodies RB4EA12 and RB4EG12 were not capable
of BL staining at any stage of C2C12 cell differentiation, in
accordance with their supposed neural origin.
Attempts to detect possible changes in the abundance of HS
epitopes in denervated skeletal muscle proved to be elusive.
Endomysial and neural BLs persist after damage or degeneration
of either muscle or nerve cells, or both (Hall and Sanes, 1993).
Synaptic and extrasynaptic proteoglycan deposits are conserved
in both size and morphology in denervated skeletal muscle
(Anderson et al., 1984), serving as scaffolds for the regeneration
of both muscle and nerve tissue, thus causing NMJs to develop at
sites where they were present before the degeneration. Moreover,
Fadic and coworkers (1990) reported proteoglycan synthesis to be
upregulated after denervation. Recently, GAGs were shown to be
potent stimulants of insulin-like growth factor-1-mediated muscle
reinnervation (Gorio et al., 1998). Because HS binds several
growth factors involved in tissue morphogenesis and because of
the unique distribution of certain HS epitopes, we suspect certain
roles for HS epitopes in this regeneration process.
In conclusion, we show that it is possible to select for highly
specific anti-HS antibodies against GAG preparations from skel-
etal muscle. The antibody-defined HS epitopes have distinct dis-
tribution characteristics in skeletal muscle BL and are similarly
distributed in humans, rats, and mice. Obvious differences in
extrasynaptic and synaptic BL staining were observed in mature
versus developing skeletal muscle. The unique distribution pat-
terns in skeletal muscle of the HS epitopes recognized by the scFv
antibodies described in this article, both in time and in space,
raise questions as to the biological roles of these HS epitopes. Of
special interest are their roles in myogenesis, more specifically in
synaptogenesis and the accompanying postsynaptic specializa-
tions such as the clustering of AChRs and other ion channels. The
occurrence of these HS epitopes in HSPGs that have already been
implicated in developmental processes awaits further investiga-
tion. Tools are now available to study more accurately the role of
HS epitopes separate from their core protein.
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